Figure 1. Research Method Flow Chart 15
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 20
Figure 4. Global Biopharmaceuticals Market, 2023-2033, $ mn 23
Figure 5. Impact of COVID-19 on Business 28
Figure 6. Primary Drivers and Impact Factors of Global Biopharmaceuticals Market 33
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 36
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022 37
Figure 10. Primary Restraints and Impact Factors of Global Biopharmaceuticals Market 42
Figure 11. Investment Opportunity Analysis 46
Figure 12. Porter’s Fiver Forces Analysis of Global Biopharmaceuticals Market 49
Figure 13. Breakdown of Global Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue 54
Figure 14. Global Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%) 54
Figure 15. Global Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn 55
Figure 16. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn 56
Figure 17. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn 57
Figure 18. Global Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn 58
Figure 19. Global Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn 59
Figure 20. Global Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn 60
Figure 21. Global Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn 61
Figure 22. Global Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn 62
Figure 23. Global Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn 63
Figure 24. Global Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn 64
Figure 25. Global Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn 65
Figure 26. Global Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn 66
Figure 27. Global Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn 67
Figure 28. Global Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn 68
Figure 29. Global Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn 69
Figure 30. Global Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn 70
Figure 31. Global Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn 71
Figure 32. Global Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn 72
Figure 33. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn 73
Figure 34. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn 75
Figure 35. Global Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn 76
Figure 36. Global Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn 77
Figure 37. Global Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn 78
Figure 38. Global Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn 80
Figure 39. Global Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn 81
Figure 40. Global Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn 82
Figure 41. Global Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn 83
Figure 42. Global Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn 84
Figure 43. Global Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn 85
Figure 44. Global Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn 86
Figure 45. Global Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn 87
Figure 46. Global Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn 88
Figure 47. Global Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn 89
Figure 48. Global Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn 90
Figure 49. Global Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn 91
Figure 50. Global Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn 92
Figure 51. Global Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn 93
Figure 52. Breakdown of Global Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue 95
Figure 53. Global Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%) 95
Figure 54. Global Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn 96
Figure 55. Global Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn 97
Figure 56. Global Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn 98
Figure 57. Breakdown of Global Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue 100
Figure 58. Global Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%) 100
Figure 59. Global Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn 101
Figure 60. Global Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn 102
Figure 61. Global Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn 103
Figure 62. Breakdown of Global Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue 105
Figure 63. Global Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%) 105
Figure 64. Global Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn 106
Figure 65. Global Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn 107
Figure 66. Breakdown of Global Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue 109
Figure 67. Global Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%) 109
Figure 68. Global Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn 110
Figure 69. Global Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn 111
Figure 70. Global Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn 112
Figure 71. Global Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn 113
Figure 72. Global Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn 114
Figure 73. Global Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn 115
Figure 74. Global Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn 116
Figure 75. Global Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn 117
Figure 76. Global Market Snapshot by Region 118
Figure 77. Geographic Spread of Worldwide Biopharmaceuticals Market, 2023-2033, % of Sales Revenue 119
Figure 78. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%) 120
Figure 79. North American Biopharmaceuticals Market, 2023-2033, $ mn 123
Figure 80. Breakdown of North America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 124
Figure 81. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 125
Figure 82. U.S. Biopharmaceuticals Market, 2023-2033, $ mn 127
Figure 83. Venture Capital Deal Activity and Investment Flows in the U.S., 2013-2022, $ bn and Deal Counts 127
Figure 84. Canada Biopharmaceuticals Market, 2023-2033, $ mn 129
Figure 85. Biopharmaceuticals Market in Mexico, 2023-2033, $ mn 131
Figure 86. European Biopharmaceuticals Market, 2023-2033, $ mn 134
Figure 87. Breakdown of European Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 135
Figure 88. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 136
Figure 89. Biopharmaceuticals Market in Germany, 2023-2033, $ mn 137
Figure 90. Biopharmaceuticals Market in U.K., 2023-2033, $ mn 139
Figure 91. Biopharmaceuticals Market in France, 2023-2033, $ mn 141
Figure 92. Biopharmaceuticals Market in Spain, 2023-2033, $ mn 143
Figure 93. Biopharmaceuticals Market in Italy, 2023-2033, $ mn 145
Figure 94. Biopharmaceuticals Market in Netherlands, 2023-2033, $ mn 147
Figure 95. Biopharmaceuticals Market in Rest of Europe, 2023-2033, $ mn 149
Figure 96. Asia-Pacific Biopharmaceuticals Market, 2023-2033, $ mn 152
Figure 97. Breakdown of APAC Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 152
Figure 98. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 154
Figure 99. Biopharmaceuticals Market in Japan, 2023-2033, $ mn 156
Figure 100. Biopharmaceuticals Market in China, 2023-2033, $ mn 158
Figure 101. Biopharmaceuticals Market in Australia, 2023-2033, $ mn 160
Figure 102. Biopharmaceuticals Market in India, 2023-2033, $ mn 162
Figure 103. Biopharmaceuticals Market in South Korea, 2023-2033, $ mn 164
Figure 104. Biopharmaceuticals Market in Rest of APAC, 2023-2033, $ mn 166
Figure 105. South America Biopharmaceuticals Market, 2023-2033, $ mn 169
Figure 106. Breakdown of South America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 169
Figure 107. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 170
Figure 108. Biopharmaceuticals Market in Argentina, 2023-2033, $ mn 171
Figure 109. Biopharmaceuticals Market in Brazil, 2023-2033, $ mn 173
Figure 110. Biopharmaceuticals Market in Chile, 2023-2033, $ mn 175
Figure 111. Biopharmaceuticals Market in Rest of South America, 2023-2033, $ mn 177
Figure 112. Biopharmaceuticals Market in Middle East and Africa (MEA), 2023-2033, $ mn 179
Figure 113. Breakdown of MEA Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 179
Figure 114. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 180
Figure 115. Biopharmaceuticals Market in UAE, 2023-2033, $ mn 181
Figure 116. Biopharmaceuticals Market in Saudi Arabia, 2023-2033, $ mn 183
Figure 117. Biopharmaceuticals Market in South Africa, 2023-2033, $ mn 185
Figure 118. Growth Stage of Global Biopharmaceuticals Industry over the Forecast Period 188
Figure 119. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn 190